In patients with COVID-19 admitted to the ICU with a high acuity of illness and a prolonged period of mechanical ventilation, the time to start rehabilitation was often delayed because of the severity of an individual’s condition.
The findings of a preliminary analysis suggest that COVID-19 may not be characterized by cytokine storm and therefore the benefit of anticytokine therapies remains to be determined.
A patient with a history of achalasia presents to the emergency department with pneumonia that quickly leads to hypoxic respiratory failure.
Patients treated with tocilizumab were 44% less likely to progress to mechanical ventilation or death compared with placebo.
People with asthma were not overrepresented in patients with severe pneumonia because of SARS-CoV-2 infection who required hospitalization.
Expired or previously used and sterilized N95 respirators can be used when new N95 respirators are unavailable during the COVID-19 pandemic.
A distance learning program is effective for reducing outpatient prescribing for pediatric acute respiratory tract infection visits.
Delayed treatment of upper respiratory tract infections with antibiotics is associated with an increased risk for hospital admissions.
Among infants with severe bronchiolitis, those with rhinovirus at hospitalization followed by a new rhinovirus infection had the highest risk of recurrent wheezing.
ICU mortality from COVID-19 is lower than initially thought, with a combined mortality of 41.6% based on 24 studies.
